Stable Ischemic Heart Disease: Maximizing Quality of Life
CONTINUING EDUCATION
RN, NP: 1 CE Credit (includes 1 contact hour of pharmacology)
Release Date: September 2010
Tell A Friend...
about this continuing education opportunity! Simply enter the email address of up to 3 colleagues, friends or family members and we will email them information about this program.
|
|
PRESENTER:
Bernard R. Chaitman, MD, FRCP(c), FACC, FAHA
Professor of Medicine, Director of Cardiovascular Research
Director of the Core ECG/MI Classification Laboratory
St. Louis University School of Medicine
St. Louis, MO
Biography
COURSE OVERVIEW:
This course will feature the COURAGE and BARI 2D trial results, with a special emphasis on nurse case management for delivering optimal medical care. It will also include a brief review of the different drug classes for management of angina. The COURAGE and BARI 2D trial in patients with chronic ischemic heart disease both reported that an initial strategy of routinely adding percutaneous coronary intervention (PCI) to optimal medical therapy in the absence of significant left main coronary disease did not increase survival rates or prevent myocardial infarction. The BARI 2D trial in patients with type 2 diabetes included coronary bypass surgery (CABG) as well as PCI as an initial revascularization strategy. The BARI 2D trial reported that a strategy of prompt CABG and optimal medical care was superior to initial optimal medical care alone in preventing subsequent myocardial infarction.
EDUCATIONAL OBJECTIVES:
Upon completion of this program, participants will be able to:
- Cite recent trial data on which patients with stable ischemic heart disease benefit from coronary revascularization.
- Explain the role of the nursing professional in the application of optimal medical care for chronic ischemic heart disease.
- List the 4 specific drug classes to treat angina symptoms and differences in how they work to alleviate angina.
PRESENTER DISCLOSURES:
Speaking: Gilead
Consultant: Merck, Pfizer, Eli Lilly
AUDIENCE:
Nurses, nurse practitioners, and other healthcare professionals interested in the prevention and management of cardiovascular disease.
COST:
This online educational activity is offered free of charge.
PARTICIPATION IN THE ACTIVITY AND RECEIPT OF CERTIFICATE OF CREDIT:
View the program materials, complete the online evaluation at the end of the activity, and print your CE certificate.
SPONSOR/ACCREDITOR:
This activity is sponsored by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is accredited by the American Academy of Nurse Practitioners (AANP) as an approved provider of nurse practitioner continuing education, provider number 030602. This program is accredited for one contact hour of continuing education, which includes one hour of pharmacology. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.
GRANTOR:
This program is being presented by the Preventive Cardiovascular Nurses Association (PCNA) through an educational grant from Gilead Sciences.
|